Oncolytics Biotech, Inc. Common Shares Stock Prediction
AI-powered sentiment analysis and prediction trends for ONCY, updated each market day.
ONCY AI Sentiment
AI predicts Oncolytics Biotech, Inc. Common Shares stock is likely to decrease over the next 10 market days.
Prediction date: Sept. 23, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Oncolytics Biotech, Inc. Common Shares
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.
Sector
Exchange
Market Cap
$98,183,088
Cap Tier
Employees
29
Headquarters
SAN DIEGO, CA
Listed Since
Oct. 5, 2001
ONCY Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ONCY Volatility
Oncolytics Biotech, Inc. Common Shares has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
